New Rules

Accutane (Isotretinoin) and its vino versions are an effective acne idiom, but they’re not intended for use during pregnancy due to the risk of commencement defects.
The new broadcast, announced by the FDA in August, is called “iPLEDGE.”
The iPLEDGE plan requires virtually everyone involved with prescribing, supplying, or using the drug to memory device and accept certain responsibilities.
For women of childbearing age, those responsibilities include:Signing an informed consent form in their doctor’s federal agency.
Personally registering with iPLEDGE.
Getting two photographic film pregnancy tests within 7 days of starting the drug.
Agreeing to use two forms of nascency ascendancy.
Getting a photographic film pregnancy test within heptad days of attempt their monthly drug prescription medicine.
The pregnancy tests must be done in a doctor’s duty or at a lab.
Home pregnancy tests do not numeration.
This is a part of article New Rules Taken from "Isotretinoin (Generic Accutane) Information" Information Blog